Gene vaccination with naked plasmid DNA: Mechanism of CTL priming

被引:396
作者
Corr, M
Lee, DJ
Carson, DA
Tighe, H
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093
关键词
D O I
10.1084/jem.184.4.1555
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The injection of naked plasmid DNA directly into the muscle cells of mice has been shown to induce potent humoral and cellular immune responses. The generation of a cytotoxic T lymphocyte (CTL) response after plasmid DNA injection may involve the presentation of the expressed antigen in the context of the injected myocytes' endogenous major histocompatibility (MHC)-encoded class I molecules or may use the MHC molecules of bone marrow-derived antigen presenting cells (APC) which are capable of providing co-stimulation as well. To resolve which cell type provides the specific restricting element for this method of vaccination we generated parent-->F1 bone marrow chimeras in which H-2(oxd) recipient mice received bone marrow that expressed only H-2(b) or H-2(d) MHC molecules. These mice were injected intramuscularly with naked plasmid DNA that encoded the nucleoprotein from the A/PR/8/34 influenza strain, which as a single antigen has epitopes for both H-2D(b) and H-2K(d). The resulting CTL responses were restricted to the MHC haplotype of the bone marrow alone and not to the second haplotype expressed by the recipient's myocytes. The role of somatic tissues that express protein from injected plasmids may be to serve as a reservoir for that antigen which is then transferred to the APC. Consequently, our data show that the mechanism of priming in this novel method for vaccination uses the MHC from bone marrow-derived APC, which are efficient at providing all of the necessary signals for priming the T cell.
引用
收藏
页码:1555 / 1560
页数:6
相关论文
共 41 条
  • [11] HARDING CV, 1994, J IMMUNOL, V153, P4925
  • [12] THE IMMUNOBIOLOGY OF MUSCLE
    HOHLFELD, R
    ENGEL, AG
    [J]. IMMUNOLOGY TODAY, 1994, 15 (06): : 269 - 274
  • [13] In vivo cross-priming of MHC class I - Restricted antigens requires the TAP transporter
    Huang, AYC
    Bruce, AT
    Pardoll, DM
    Levitsky, HI
    [J]. IMMUNITY, 1996, 4 (04) : 349 - 355
  • [14] ROLE OF BONE-MARROW-DERIVED CELLS IN PRESENTING MHC CLASS I-RESTRICTED TUMOR-ANTIGENS
    HUANG, AYC
    GOLUMBEK, P
    AHMADZADEH, M
    JAFFEE, E
    PARDOLL, D
    LEVITSKY, H
    [J]. SCIENCE, 1994, 264 (5161) : 961 - 965
  • [15] ANTIGEN PRESENTATION BY CHEMICALLY MODIFIED SPLENOCYTES INDUCES ANTIGEN-SPECIFIC T-CELL UNRESPONSIVENESS INVITRO AND INVIVO
    JENKINS, MK
    SCHWARTZ, RH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) : 302 - 319
  • [16] A PHAGOSOME-TO-CYTOSOL PATHWAY FOR EXOGENOUS ANTIGENS PRESENTED ON MHC CLASS-I MOLECULES
    KOVACSOVICSBANKOWSKI, M
    ROCK, KL
    [J]. SCIENCE, 1995, 267 (5195) : 243 - 246
  • [17] FIBROBLASTS AS EFFICIENT ANTIGEN-PRESENTING CELLS IN LYMPHOID ORGANS
    KUNDIG, TM
    BACHMANN, MF
    DIPAOLO, C
    SIMARD, JJL
    BATTEGAY, M
    LOTHER, H
    GESSNER, A
    KUHLCKE, K
    OHASHI, PS
    HENGARTNER, H
    ZINKERNAGEL, RM
    [J]. SCIENCE, 1995, 268 (5215) : 1343 - 1347
  • [18] INDUCTION OF TOLERANCE IN INFLUENZA VIRUS-IMMUNE LYMPHOCYTE-T CLONES WITH SYNTHETIC PEPTIDES OF INFLUENZA HEMAGGLUTININ
    LAMB, JR
    SKIDMORE, BJ
    GREEN, N
    CHILLER, JM
    FELDMANN, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (05) : 1434 - 1447
  • [19] MANICKAN E, 1995, J IMMUNOL, V155, P259
  • [20] MARTINEZKINADER B, 1995, IMMUNOLOGY, V86, P287